Protein therapeutics: A summary and pharmacological classification

被引:1569
作者
Leader, Benjamin [3 ]
Baca, Quentin J. [1 ,2 ]
Golan, David E. [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Dept Biochem & Mol Pharmacol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA
[3] Brown Med Sch, Dept Emergency Med, Providence, RI USA
关键词
D O I
10.1038/nrd2399
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Once a rarely used subset of medical treatments, protein therapeutics have increased dramatically in number and frequency of use since the introduction of the first recombinant protein therapeutic-human insulin-25 years ago. Protein therapeutics already have a significant role in almost every field of medicine, but this role is still only in its infancy. This article overviews some of the key characteristics of protein therapeutics, summarizes the more than 130 protein therapeutics used currently and suggests a new classification of these proteins according to their pharmacological action.
引用
收藏
页码:21 / 39
页数:19
相关论文
共 301 条
[81]   Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer [J].
Ferrara, N ;
Hillan, KJ ;
Gerber, HP ;
Novotny, W .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (05) :391-400
[82]   Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: Long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty [J].
Feuillan, PP ;
Jones, JV ;
Barnes, K ;
Oerter-Klein, K ;
Cutler, GB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (01) :44-49
[83]  
Finfer S, 2004, NEW ENGL J MED, V350, P2247
[84]   Effect of growth hormone therapy on height in children with idiopathic short stature - A meta-analysis [J].
Finkelstein, BS ;
Imperiale, TF ;
Speroff, T ;
Marrero, U ;
Radcliffe, D ;
Cuttler, L .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2002, 156 (03) :230-240
[85]   Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis - A large, international, multicenter, placebo-controlled trial [J].
Fleischmann, RM ;
Schechtman, J ;
Bennett, R ;
Handel, ML ;
Burmester, GR ;
Tesser, J ;
Modafferi, D ;
Poulakos, J ;
Sun, G .
ARTHRITIS AND RHEUMATISM, 2003, 48 (04) :927-934
[86]   Rational design of aggregation-resistant bioactive peptides: Reengineering human calcitonin [J].
Fowler, SB ;
Poon, S ;
Muff, R ;
Chiti, F ;
Dobson, CM ;
Zurdo, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (29) :10105-10110
[87]   CUZN SUPEROXIDE-DISMUTASE (SOD-1)-TETANUS TOXIN FRAGMENT-C HYBRID PROTEIN FOR TARGETED DELIVERY OF SOD-1 TO NEURONAL CELLS [J].
FRANCIS, JW ;
HOSLER, BA ;
BROWN, RH ;
FISHMAN, PS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (25) :15434-15442
[88]   TREATMENT OF APLASTIC-ANEMIA WITH ANTILYMPHOCYTE GLOBULIN AND METHYLPREDNISOLONE WITH OR WITHOUT CYCLOSPORINE [J].
FRICKHOFEN, N ;
KALTWASSER, JP ;
SCHREZENMEIER, H ;
RAGHAVACHAR, A ;
VOGT, HG ;
HERRMANN, F ;
FREUND, M ;
MEUSERS, P ;
SALAMA, A ;
HEIMPEL, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (19) :1297-1304
[89]   Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. [J].
Fried, MW ;
Shiffman, ML ;
Reddy, KR ;
Smith, C ;
Marinos, G ;
Goncales, FL ;
Haussinger, D ;
Diago, M ;
Carosi, G ;
Dhumeaux, D ;
Craxi, A ;
Lin, A ;
Hoffman, J ;
Yu, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :975-982
[90]  
Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151